Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions

摘要

Carboplatin is an effective and well-tolerated chemotherapeutic agent used as first-line and subsequent treatment for ovarian cancer. Hypersensitivity reactions to chemotherapy have increased in frequency in the last 20 years, thus preventing the use of first-line therapies and causing a negative impact on patient survival and quality of life [1,2].